Cita APA

Hu, X., Zhang, L., Dong, Y., Dong, C., Jiang, J., & Gao, W. (2018). Switching from biosimilar (Basalin) to originator (Lantus) insulin glargine is effective in Chinese patients with diabetes mellitus: A retrospective chart review. F1000Res.

Chicago Style Citation

Hu, Xia, Lei Zhang, Yanhu Dong, Chao Dong, Jikang Jiang, i Weiguo Gao. "Switching From Biosimilar (Basalin) to Originator (Lantus) Insulin Glargine Is Effective in Chinese Patients With Diabetes Mellitus: A Retrospective Chart Review." F1000Res 2018.

Cita MLA

Hu, Xia, et al. "Switching From Biosimilar (Basalin) to Originator (Lantus) Insulin Glargine Is Effective in Chinese Patients With Diabetes Mellitus: A Retrospective Chart Review." F1000Res 2018.